BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that on January 26, 2023, Spectrum’s ...
Spectrum Designs Foundation was recently awarded a $10,000 grant from the TD Charitable Foundation, the charitable giving arm of TD Bank. This grant will support the Disabilities Employment Training ...